Clinical Trials Sponsored by Institut Bergonié

Total 74494 results

Institut Guttmann

Unknown

Efficacy and Safety of rTMS Plus Rehabilitation for the Improvement of the Upper Extremity in Stroke (ERES) (ERES)

Stroke | Arm Paralysis
Institut Curie

Completed

Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.

Metastatic Breast Cancer, HER2 Negative Primary Tumor

France
Institut Curie

Completed

Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer (CirCé01)

Breast Cancer Ductal Infiltrating Metastatic

France
Institut Pasteur

Unknown

Understanding Tick-borne Diseases (OHTICKS)

Lyme Disease

France
Institut Pasteur

Completed

Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine

Shigella Infection

France, United Kingdom
Institut Pasteur

Completed

Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot Study (ALSCELL)

Amyotrophic Lateral Sclerosis

France
Institut Pasteur

Completed

SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers

Shigellosis | Bacillary Dysentery

Israel
Institut Guttmann

Completed

Diaphragmatic Pacer Placement: Anesthetic Management (DP) (DP)

Amyotrophic Lateral Sclerosis | Spinal Cord Injuries | Respiratory Paralysis
Institut Curie

Completed

Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care Consultation (QUEPAL)

Metastatic Cancer | Palliative Care

France
Institut Curie

Completed

Characterisation of Biofilm of the Chronic Wounds (Biofilm Plaie)

Chronic Wounds

France
Institut Curie

Completed

Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel (ALCOOTAX)

Tumors

France
Institut Curie

Not yet recruiting

Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method Study (SALOME Quali)

Uveal Melanoma
Institut Curie

Recruiting

Study for the Reliability and Validity of the EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 Questionnaires (PATSAT)

Cancer

France
Institut Guttmann

Recruiting

Prehabilitation, Rehabilitation and Comprehensive Approach to the Sequelae of Brain Tumors (PREHABILITA)

Brain Tumor

Spain
Institut Curie

Recruiting

Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment (GrannyFit)

Breast Cancer

France
Institut Curie

Recruiting

Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)

Cancer

France
Institut Curie

Recruiting

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures (PACsign)

Carcinoma, Pancreatic Ductal | Prognosis

France
Institut Curie

Recruiting

ProActIF-01 Trial: Randomized Study of Evaluation of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Lung or Digestive Cancers (ProActIF-01)

CANCER

France
Institut Curie

Recruiting

Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study. (OFOBA)

Breast Cancer

France
Institut Curie

Recruiting

Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE)

Prostate Cancer | Healthy Donors

France
Institut Curie

Recruiting

Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4 (ALCINA4)

Cancer

France
Institut Curie

Recruiting

Exenteration: Quality of Life Study and Rehabilitation Rate According to the Reconstruction Technique (ETRE) (ETRE)

Cancer

France
Institut Curie

Recruiting

Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG (REAL-MOOV-LUNG)

Lung Cancer

France
Institut Pasteur

Recruiting

Study of the Incidence of Jarisch-Herxheimer Reaction in Leptospirosis Patients in New Caledonia (LEPJARNC)

Leptospirosis | Jarisch Herxheimer Reaction

New Caledonia
Institut Curie

Recruiting

First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide)

Metastatic Solid Tumor Cancer

France
Institut Curie

Recruiting

Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer (MONDRIAN)

HER2-negative Metastatic Breast Cancer

France
Institut Pasteur

Recruiting

Creation of a Prospective Cohort of Healthy and Sick Subjects and of a Collection of Associated Biological Resources, for the Study of the Immune System and of Its Genetic and Environmental Determinants. (CoSImmGEn)

Immune System and Related Disorders

France
Institut Pasteur

Recruiting

Simian Foamy Virus Transmission to Humans

Simian Foamy Virus Infection (Disorder)

Cameroon
Institut Curie

Recruiting

Prospective Biobanking Study in Ovarian, Breast, Head and Neck and Cervical Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) (SCANDARE)

Cervical Cancer | Head and Neck Cancer | Ovarian Cancer | Triple-Negative Breast Cancer

France
Institut Rafael

Completed

Cross-sectional Survey of Sexual Health in Cancer Patients (S&C)

Integrative Oncology

France
Institut Curie

Terminated

Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer (OPTICOACH)

Breast Cancer | Surgery

France
Institut Rafael

Active, not recruiting

Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim (PELGRAZ)

Patient Satisfaction | Patient Preference | Febrile Neutropenia, Drug-Induced

France
Institut Curie

Active, not recruiting

SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02) (SHIVA02)

Cancer | Solid Tumor, Adult

France
Institut Curie

Active, not recruiting

The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI)

Cancer, Advanced

France
Institut Curie

Active, not recruiting

Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers (PROTONCHORDE01)

Skull Base Chordoma | Vertebral Chordoma

France
Institut Curie

Completed

Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor - NGSKids (NGSKids)

Metastatic and/or High Risk Solid Tumor of Children

France
Institut Curie

Completed

Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

Choroidal Melanoma, Diffuse

France
Institut Curie

Completed

Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU) (ctDNA MU)

Choroidal Melanoma

France
Institut Curie

Completed

MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery

Malignant Neoplasm of Breast

France
Institut Curie

Active, not recruiting

Use of Virtual Reality Mask or Music Therapy for Analgesia and Anxiolytic Purpose When Totally IVAD for Chemotherapy Under Local Anesthesia (REVCCI)

Implanted Venous Access Device

France
Institut Pasteur

Terminated

Toi Même: a Mobile System for Measuring Bipolar Illness

Bipolar Disorder

France
Institut Curie

Active, not recruiting

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Triple Negative Breast Cancer | Pediatric Cancer | Metastatic Uveal Melanoma | Luminal B Breast Cancer

France
Institut Pasteur

Completed

Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19] (COVID-OISE)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

France
Institut Curie

Completed

Breast Cancer Risk After Diagnostic Gene Sequencing (BRIDGEScohort2)

Genetic Predisposition to Disease

France, Germany
Institut Pasteur

Completed

Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity (INECOC)

Squamous Cell Carcinoma of the Oral Cavity | Leukoplakia Oral

France
Institut Pasteur

Withdrawn

Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal (NeoVac2S)

Hepatitis B
Institut Curie

Terminated

Innovation for Standard Identification of Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cancer: Towards Development of Personalized Biomarkers in Clinical Oncology (PAIR HPV)

Cervical Cancer

France
Institut Guttmann

Unknown

Clinical Trial of The Boosting Effect of Transcranial Random Noise Stimulation (tRNS) in Cognitive Rehabilitation of Patients With Traumatic Brain Injury (TRUST)

Cognitive Impairment | Traumatic Brain Injury

Spain
Institut Curie

Unknown

Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

Ductal Infiltrating Metastatic Breast Cancer | Hormone-receptors Positive Breast Cancer

France
Institut Curie

Completed

Test Semiquantitative Prostate Specific Antigen (PSA)

Prostatic Neoplasms | Prostatic Diseases | Prostate Cancer

France

3

Subscribe